A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
Brivio E, Locatelli F, Lopez-Yurda M, Malone A, Díaz-de-Heredia C, Bielorai B, Rossig C, van der Velden VHJ, Ammerlaan ACJ, Thano A, van der Sluis IM, den Boer ML, Chen Y, Sleight B, Brethon B, Nysom K, Sramkova L, Øra I, Vinti L, Chen-Santel C, Zwaan CM.
Brivio E, et al. Among authors: nysom k.
Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848.
Blood. 2021.
PMID: 33067614
Free PMC article.
Clinical Trial.